Search Results - "PI3K"

"Huanglianjiedu Decoction" Against Pancreatic Adenocarcinoma Proliferation of by Downregulating the PI3K/AKT/mTOR and MAPK/ERK1/2 Signaling Pathways by Shu Dong, MD, Panling Xu, MD, Peiwen Yang, MD, Juying Jiao, MD, Chien-shan Cheng, MD, PhD, Lianyu Chen, MD, PhD

Connect to this object online.

Lipid Signaling in T Cell Development and Function by Karsten Sauer

Subjects: “…PI3K…”
DOAB: download the publication
DOAB: description of the publication

Plumbagin induces RPE cell cycle arrest and apoptosis via p38 MARK and PI3K/AKT/mTOR signaling pathways in PVR by Haiting Chen, Huifang Wang, Jianbin An, Qingli Shang, Jingxue Ma

Connect to this object online.

Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines by Xin P, Li C, Zheng Y, Peng Q, Xiao H, Huang Y, Zhu X

Connect to this object online.

Resveratrol liposomes reverse sorafenib resistance in renal cell carcinoma models by modulating PI3K-AKT-mTOR and VHL-HIF signaling pathways by Ligang Wang, Ying Wang, Qiqi Xie, Songcheng Xu, Chen Yang, Fei Liu, Yang Liu, Fuwei Wang, Weinan Chen, Jianchun Li, Litao Sun

Connect to this object online.

Tetramethylpyrazine Analogue T-006 Protects Neuronal and Endothelial Cells Against Oxidative Stress via PI3K/AKT/mTOR and Nrf2 Signaling by Guiliang Zhang, Zirong Liang, Yuqiang Wang, Zaijun Zhang, Pui-Man Hoi

Connect to this object online.

Liraglutide Attenuates Diabetic Cardiomyopathy via the ILK/PI3K/AKT/PTEN Signaling Pathway in Rats with Streptozotocin-Induced Type 2 Diabetes Mellitus by Shatha M. Alobaid, Rahaf M. Alshahrani, Asma S. Alonazi, Nawal M. Alrasheed, Maha A. Alamin, Tahani K. Alshammari, Anfal F. Bin Dayel, Doaa M. Elnagar, Rana R. Alotaibi, Lama A. Almuthnabi, Dalia H. Almasud, Shahad E. Al-Ammar, Shahad O. Almadhi, Reema A. Almalke, Nouf T. Aldamri, Hanan K. Alghibiwi, Dalal A. Alkhelb, Nouf M. Alrasheed

Connect to this object online.

Gallic Acid Inhibits Bladder Cancer T24 Cell Progression Through Mitochondrial Dysfunction and PI3K/Akt/NF-κB Signaling Suppression by Maolin Zeng, Maolin Zeng, Yang Su, Yang Su, Yang Su, Kuangyu Li, Kuangyu Li, Dan Jin, Qiaoling Li, Yan Li, Benhong Zhou, Benhong Zhou

Connect to this object online.

C2CD4B Evokes Oxidative Stress and Vascular Dysfunction via a PI3K/Akt/PKCα-Signaling Pathway by Paola Di Pietro, Angela Carmelita Abate, Valeria Prete, Antonio Damato, Eleonora Venturini, Maria Rosaria Rusciano, Carmine Izzo, Valeria Visco, Michele Ciccarelli, Carmine Vecchione, Albino Carrizzo

Connect to this object online.

Genetic Deletion and Pharmacological Inhibition of PI3Kγ Reduces Neutrophilic Airway Inflammation and Lung Damage in Mice with Cystic Fibrosis-Like Lung Disease by Maria Galluzzo, Elisa Ciraolo, Monica Lucattelli, Eriola Hoxha, Martina Ulrich, Carlo Cosimo Campa, Giuseppe Lungarella, Gerd Doring, Zhe Zhou-Suckow, Marcus Mall, Emilio Hirsch, Virginia De Rose

Connect to this object online.

Dual inhibition of MEK and PI3Kβ/δ-a potential therapeutic strategy in PTEN-wild-type docetaxel-resistant metastatic prostate cancer by Vicenç Ruiz de Porras, Vicenç Ruiz de Porras, Vicenç Ruiz de Porras, Adrià Bernat-Peguera, Adrià Bernat-Peguera, Clara Alcon, Fernando Laguia, Maria Fernández-Saorin, Maria Fernández-Saorin, Natalia Jiménez, Ana Senan-Salinas, Ana Senan-Salinas, Carme Solé-Blanch, Carme Solé-Blanch, Andrea Feu, Mercedes Marín-Aguilera, Juan Carlos Pardo, Juan Carlos Pardo, Juan Carlos Pardo, Maria Ochoa-, Maria Ochoa-, Maria Ochoa-, Joan Montero, Begoña Mellado, Begoña Mellado, Albert Font, Albert Font, Albert Font

Connect to this object online.

CCR9 interactions support ovarian cancer cell survival and resistance to cisplatin-induced apoptosis in a PI3K-dependent and FAK-independent fashion by Johnson Erica L, Singh Rajesh, Johnson-Holiday Crystal M, Grizzle William E, Partridge Edward E, Lillard James W, Singh Shailesh

Connect to this object online.

Yishen paidu pills attenuates 5/6 nephrectomy induced kidney disease via inhibiting the PI3K/AKT/mTOR signaling pathway by Saiji Liu, Yiling Cao, Qian Yuan, Yaru Xie, Yuting Zhu, Lijun Yao, Chun Zhang

Connect to this object online.

Paeoniflorin Inhibits Mesangial Cell Proliferation and Inflammatory Response in Rats With Mesangial Proliferative Glomerulonephritis Through PI3K/AKT/GSK-3β Pathway by Bihao Liu, Jin Lin, Lixia Bai, Yuan Zhou, Ruirui Lu, Peichun Zhang, Dandan Chen, Honglian Li, Jianping Song, Xusheng Liu, Yifan Wu, Junbiao Wu, Chunling Liang, Jiuyao Zhou

Connect to this object online.

Kochia scoparia seed extract suppresses VEGF-induced angiogenesis via modulating VEGF receptor 2 and PI3K/AKT/mTOR pathways by Hyun-Dong Cho, Jeong-Ho Kim, Jun-Kyu Park, Seong-Min Hong, Du-Hyun Kim, Kwon-Il Seo

Connect to this object online.

Protective effect of dexmedetomidine against delayed bone healing caused by morphine via PI3K/Akt mediated Nrf2 antioxidant defense system by Yani Lou, Yani Lou, Linfang Zou, Zhenyu Shen, Jianwei Zheng, Yuanqu Lin, Zhe Zhang, XuanKuai Chen, Jun Pan, Xutong Zhang, Xutong Zhang

Connect to this object online.

Berberine Induced Apoptosis of Human Osteosarcoma Cells by Inhibiting Phosphoinositide 3 Kinase/Protein Kinase B (PI3K/Akt) Signal Pathway Activation by Zhi-Ze CHEN

Connect to this object online.

Ferulic Acid Methyl Ester Attenuates Cerebral Ischemia-Reperfusion Injury in Rats by Modulating PI3K/HIF-1α/VEGF Signaling Pathway by Zhou P, Yu S, Wang X, Zhang X, Guo D, Zhao C, Cheng J, Wang J, Sun J

Connect to this object online.

Honokiol Provides Cardioprotection from Myocardial Ischemia/Reperfusion Injury (MI/RI) by Inhibiting Mitochondrial Apoptosis via the PI3K/AKT Signaling Pathway by Linhua Lv, Qiuhuan Kong, Zhiying Li, Ying Zhang, Bijiao Chen, Lihua Lv, Yubi Zhang

Connect to this object online.

Mangiferin Ameliorates Cisplatin Induced Acute Kidney Injury by Upregulating Nrf-2 via the Activation of PI3K and Exhibits Synergistic Anticancer Activity With Cisplatin by Pritam Sadhukhan, Sukanya Saha, Sayanta Dutta, Parames C. Sil

Connect to this object online.